All data were fit to a single site binding model included in the data analysis package provided by MicroCal
caldus are presented in Table 1, and the primers are presented in Table 2
MHC class proteins usefull as immunologically active molecules may be complete trimer molecule complexes or parts of MHC class 1 molecules as follows: o Heavy chains o Heavy chains combined with beta2microglobulin o Heavy chains combined with beta2microglobulin and antigenic peptide o Heavy chain combined with antigenic peptide o Beta2mcroglobulin MHC class 1 -like molecules: o MICA, MICB o CD1d o HLA-E, HLA-F, HLA-G, HLA-H o ULBP-1 , ULBP-2, ULBP-3 MHC 2 proteins including HLA-DR (HLA-DRA, HLA-DRB1 , HLA-DRB3, HLA- DRB4, HLA-DRB5), HLA-DQ (HLA-DQA1 , HLADQA2, HLA-DQB1 , HLA- DQB2), HLA-DP (HLA-DPAI 1 HLA-DPBI ), HLA-DO (HLA-DOA, HLA-DOB), HLA-DM (HLA-DMA, HLA-DMB)
A recent cross-sectional study of unmedicated and medicated patients found that treatment may alter the association between brain glutamate levels and cognitive function [62], but since we found a stable association over two years, our findings suggest that this presumed alteration appears later in the illness phase
